Employees
717
Industry
Biological Product (except Diagnostic) Manufacturing
freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation aav gene therapy platform developed by amit nathwani, professor of haematology at ucl and cso of freeline therapeutics http://www.freelinetx.com
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
November 28, 2023 | 12:10 pm
Portfolio Pulse from Benzinga Newsdesk
November 22, 2023 | 4:42 pm
Portfolio Pulse from Vandana Singh
November 22, 2023 | 2:49 pm
Portfolio Pulse from Charles Gross
November 22, 2023 | 12:38 pm
Portfolio Pulse from Benzinga Newsdesk
November 22, 2023 | 12:36 pm
Portfolio Pulse from Charles Gross
November 22, 2023 | 12:25 pm
Portfolio Pulse from Benzinga Newsdesk
October 25, 2023 | 7:27 am
Portfolio Pulse from Benzinga Insights
October 18, 2023 | 9:00 pm
Portfolio Pulse from Lisa Levin
October 18, 2023 | 6:15 pm
Portfolio Pulse from Benzinga Newsdesk
October 18, 2023 | 2:35 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.